24/7 Field Service Engineer Hotline: +1-800-SYSMEX-1 UDI Look-up · ISO 13485 · GPO Contracts: Premier · Vizient · HealthTrust

ABOUT SYSMEX

Sysmex Clinical Research Center

Evidence workflows co-developed with academic medical centers and reference laboratories—published claims must survive peer review and post-market surveillance.

“Every performance statement we place beside an analyzer or monitor has to survive peer review and ten years of post-market surveillance—not a slide deck.” — Chief Medical Officer, Sysmex Clinical Research Center

Sysmex traces hematology and coagulation platform lineages through multi-decade IVD manufacturing (corporate roots in 1968; U.S. commercial operations expanded through the 1990s–2010s). Connected monitoring dossiers are released only when IEC 60601, cybersecurity and interoperability packets match the requested SKU. We do not publish uncited efficacy percentages or hospital-named testimonials without written authorization.

LABORATORIES & TESTING

Verification facilities behind the portfolio.

Metrology, biocompatibility, EMC, software lifecycle and usability suites support design history file (DHF) and device master record (DMR) evidence for FDA 510(k) and CE IVDR / MDR pathways—applicability is always SKU-specific.

SELECTED PUBLICATIONS

Peer-reviewed and regulatory abstracts on request.

  • Diagnostic Accuracy Meta-analysis (2021 dossier) — hematology flagging performance synthesis vs predicate methods; journal citation released under NDA
  • Real-World Evidence Registry Report (2022–2024) — multi-site CBC workflow TAT observations under CAP checklist protocols
  • Comparative Effectiveness vs Predicate Device (2020) — coagulation platform method comparison abstract with CV / LOD fields
  • 510(k) Summary Library — public release index for cleared configurations; request by UDI-DI
  • CER Abstract — MDR 2017/745 / IVDR clinical evaluation extract with post-market surveillance (PMS) annex

Named hospital partnerships and numeric outcomes are provided only through controlled dossiers. Limits: research-center methods do not transfer to every market SKU; ISO 17025 scope covers listed calibration domains only; cybersecurity red-team findings are not public CVE dumps.

Request the full clinical evidence dossier

Download (PDF, controlled release)